Home/Filings/4/0001209191-20-034450
4//SEC Filing

Manning Donald C. 4

Accession 0001209191-20-034450

CIK 0001396814other

Filed

Jun 3, 8:00 PM ET

Accepted

Jun 4, 4:48 PM ET

Size

7.8 KB

Accession

0001209191-20-034450

Insider Transaction Report

Form 4
Period: 2020-06-02
Manning Donald C.
Chief Medical Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2020-06-02+71,30071,300 total
    Exercise: $43.58Exp: 2030-06-02Common Stock (71,300 underlying)
  • Award

    Common Stock

    2020-06-02+28,50028,500 total
Footnotes (2)
  • [F1]Represents restricted stock units that vest in four equal annual installments beginning on June 1, 2021, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock.
  • [F2]The stock option vests and becomes exercisable as to 25% of the option shares on May 1, 2021, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date.

Issuer

Pacira BioSciences, Inc.

CIK 0001396814

Entity typeother

Related Parties

1
  • filerCIK 0001775268

Filing Metadata

Form type
4
Filed
Jun 3, 8:00 PM ET
Accepted
Jun 4, 4:48 PM ET
Size
7.8 KB